Research Library
Peer-reviewed and published research summaries from Kratos Research Labs, written for a technically literate audience and organized around what the current literature actually supports.
This library separates direct human evidence, review literature, and preclinical or mechanistic findings so the strongest claims stay tied to the strongest data.
- Use this page to browse the current research summaries.
- Use the individual articles for topic-level evidence review.
- Use product pages separately for research-use-only catalog access.
-
What Does the Published Research Say About Semaglutide?
Summary of semaglutide research: weight-management RCTs (primarily without diabetes), PAD walking capacity, and design-only CV and MASH trials.
-
What Does the Published Research Say About Retatrutide?
Phase 2 trials in obesity, type 2 diabetes, and MASLD exist; registrational studies are ongoing. Reviews provide context but do not establish outcomes.
-
What Does the Published Research Say About NAD+?
Most NAD+ literature is review or preclinical. Human trials are limited and narrow. This KRL summary separates human, review, and mechanistic evidence.
-
What Does the Published Research Say About Semax?
Semax research is mostly preclinical; one small human study exists. This review separates human data from animal/mechanistic findings with citations.
-
What Does the Published Research Say About Selank?
Summary of published research on Selank: largely reviews and preclinical findings; no primary human clinical outcome data found in this packet.
-
What Does the Published Research Say About Glutathione?
Glutathione research is largely mechanistic and preclinical; human data are limited to observational biomarkers, not supplementation efficacy.
-
What Does the Published Research Say About P21?
In this packet, P21 lacks human interventional data. Evidence is preclinical and contextual—target discovery, tools, and engineered platforms—not clinical efficacy.
-
What Does the Published Research Say About DSIP?
DSIP evidence is review- and animal-heavy. Human data are limited to narrow observational findings; dosing and safety are not established.
-
What Does the Published Research Say About Ipamorelin?
Ipamorelin evidence is largely review and preclinical; no large randomized human trials identified. Human conclusions should stay endpoint- and context-specific.
-
What Does the Published Research Say About Thymosin Alpha-1?
Review the published thymosin alpha-1 literature with a focus on direct human evidence, review-heavy context, preclinical signals, and the limits of broader claims.
Need current product documentation or small-order review? Small-quantity qualified research purchasers can send a KRL10 order-review request, request current COA availability, review product documentation, or use the catalog-access support path from Kratos Research Labs.
Launch-week incentive: Use code KRL10 for $10 off eligible RUO catalog orders of $100 or more. Limited to the first 10 coupon uses, one use per customer, through June 4, 2026.
Research use only. Not for human or veterinary use. Payment instructions are provided after compliance review.